Showing results (421-430 of 493) with videos related to

Sort By:
Pageof 50
Brain Sciences|December 24, 2021
Discussing Personalized Prognosis Empowers Patients with Amyotrophic Lateral Sclerosis to Regain Control over Their Future: A Qualitative StudyRemko M van Eenennaam, Loulou S Koppenol, Willeke J Kruithof, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|June 6, 2007
The membrane fouling simulator: a suitable tool for prediction and characterisation of membrane foulingJ S Vrouwenvelder, S M Bakker, M Cauchard, et al.
Cell Death & Disease|October 5, 2019
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinomaJacopo Gavini, Noëlle Dommann, Manuel O Jakob, et al.
The Lancet. Neurology|June 23, 2023
Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort studyRemko M van Eenennaam, Willeke Kruithof, Anita Beelen, et al.
European Journal of Epidemiology|March 13, 2015
Challenges in conducting genome-wide association studies in highly admixed multi-ethnic populations: the Generation R StudyCarolina Medina-Gomez, Janine Frédérique Felix, Karol Estrada, et al.
Scientific Reports|June 11, 2026
Expression of progranulin (GP88) protein appears as an independent prognostic factor for clinical progression in high-risk prostate cancer patientsRenata Dubrovska, Markus Eckstein, Rudolf Jung, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2025
Multi-layer stratified oncology platform utilizing transcriptomics, prostate cancer organoids, and modeling of drug responseJuening Kang, Panagiotis Chouvardas, Andrew Maalouf, et al.
The Journal of Biological Chemistry|October 19, 2014
Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodiesPauline A van Schouwenburg, Simone Kruithof, Christian Votsmeier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 17, 2023
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase ActivatorJonas M den Heijer, Annelieke C Kruithof, Matthijs Moerland, et al.
Nucleic Acids Research|February 13, 2024
Functional identification of cis-regulatory long noncoding RNAs at controlled false discovery ratesBhavya Dhaka, Marc Zimmerli, Daniel Hanhart, et al.
Pageof 50